Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational study.

Hidekazu ShirotaKeigo KomineMasanobu TakahashiShin Takahashi Eisaku Miyauchi Hidetaka Niizuma Hiroshi Tada Muneaki Shimada Tetsuya NiihoriYoko AokiIkuko SugiyamaMaako KawamuraJun YasudaShuhei SuzukiTakeshi Iwaya Katsuharu SaitoTsuyoshi SaitoHiroyuki Shibata Toru Furukawa Chikashi Ishioka

Published in: Cancer medicine (2022)

The results of this study may be used to simplify treatment recommendations from the CGP reports and help select patients for testing, thereby increasing the accuracy of personalized medicine.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
single cell
emergency department
dna methylation
adverse drug
genome wide